Likewise, Bosutinib inhibitor increased in vitro survival of iPSC-derived motor neurons from patients with sporadic or familial forms of ALS, caused by mutations in the TAR DNA binding protein (TDP-43) or repeat expansions in the C9orf72 gene [53]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.